Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation-Reference-Cited by-同舟云学术

Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation

Published:2020-04 Issue:4 Volume:37 Page:584-598.e11
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Zhang Zeda,Zhou Chuanli,Li Xiaoling,Barnes Spencer D.,Deng Su,Hoover Elizabeth,Chen Chi-Chao,Lee Young Sun,Zhang Yanxiao,Wang Choushi,Metang Lauren A.,Wu Chao,Tirado Carla Rodriguez,Johnson Nickolas A.,Wongvipat John,Navrazhina Kristina,Cao Zhen,Choi Danielle,Huang Chun-Hao,Linton Eliot,Chen Xiaoping,Liang Yupu,Mason Christopher E.,de Stanchina Elisa,Abida Wassim,Lujambio Amaia,Li Sheng,Lowe Scott W.,Mendell Joshua T.,Malladi Venkat S.,Sawyers Charles L.^ORCID,Mu Ping^ORCID

Funder

Cancer Moonshot

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference84 articles.

1. Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making;Abida;JCO Precis Oncol.,2017

2. Genomic correlates of clinical outcome in advanced prostate cancer;Abida;Proc. Natl. Acad Sci U S A,2019

3. Identification of a benzoisoxazoloazepine inhibitor (CPI-0610) of the bromodomain and extra-terminal (BET) family as a candidate for human clinical trials;Albrecht;J. Med. Chem.,2016

4. Toward understanding and exploiting tumor heterogeneity;Alizadeh;Nat. Med.,2015

5. Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade;Arora;Cell,2013

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer plasticity in therapy resistance: Mechanisms and novel strategies;Drug Resistance Updates;2024-09

2. Therapy resistance in prostate cancer: mechanism, signaling and reversal strategies;Exploration of Targeted Anti-tumor Therapy;2024-08-29

3. The m6A regulators in prostate cancer: molecular basis and clinical perspective;Frontiers in Pharmacology;2024-08-29

4. Treatment-induced stemness and lineage plasticity in driving prostate cancer therapy resistance;Cancer Heterogeneity and Plasticity;2024-08-25

5. YBX1 promotes homologous recombination and resistance to platinum-induced stress in ovarian cancer by recognizing m5C modification;Cancer Letters;2024-08